Latest Breaking News On - Andidate ibtb se0008015259 - Page 1 : comparemela.com

In accordance with the study protocol, the independent Data Monitoring Committee has performed the final planned safety analysis of Infant Bacterial Therapeutics AB drug candidate IBP-9414. The. | June 21, 2023

United statesUnited kingdomData monitoring committeeInfant bacterial therapeuticsNasdaq stockholmInfant bacterial therapeutics ab publ stock exchangePress releaseAndidate ibtb se0008015259